Hepatitis C News and Research

Latest Hepatitis C News and Research

Real-time elastography method depicts liver hardness: Study

Real-time elastography method depicts liver hardness: Study

Research finding suggests HCV interference with hepcidin synthesis

Research finding suggests HCV interference with hepcidin synthesis

Drug boosting production of immune system protein worsens TB

Drug boosting production of immune system protein worsens TB

Checklist to stay healthy and active during summer season

Checklist to stay healthy and active during summer season

Inhibitex provides update on ongoing Phase II clinical trial of FV-100 for shingles

Inhibitex provides update on ongoing Phase II clinical trial of FV-100 for shingles

Study shows promising basis for development of effective liver-cancer screening test

Study shows promising basis for development of effective liver-cancer screening test

WHO Director-General turns attention to conditions in slums to mark World Health Day

WHO Director-General turns attention to conditions in slums to mark World Health Day

Inovio Biomedical receives $2.8M grant to develop DNA vaccine for HCV

Inovio Biomedical receives $2.8M grant to develop DNA vaccine for HCV

IFN therapy for chronic hepatitis C must be individualized and optimized for efficacy

IFN therapy for chronic hepatitis C must be individualized and optimized for efficacy

Combination telaprevir treatment beneficial for retreatment of hepatitis C

Combination telaprevir treatment beneficial for retreatment of hepatitis C

12 infected with Hepatitis C by a doctor at clinic in Victoria

12 infected with Hepatitis C by a doctor at clinic in Victoria

Ribavirin Biopartners 200mg film-coated tablets granted EU marketing approval

Ribavirin Biopartners 200mg film-coated tablets granted EU marketing approval

Nippon Shinyaku to market and sell Labopharm's once-daily tramadol in Japan

Nippon Shinyaku to market and sell Labopharm's once-daily tramadol in Japan

Phase 1 SAD study of PSI-938 for HCV initiated

Phase 1 SAD study of PSI-938 for HCV initiated

Telaprevir-based regimens increase rates of SVR in patients with genotype 1 HCV infection

Telaprevir-based regimens increase rates of SVR in patients with genotype 1 HCV infection

Secretary of Health announces five health research grants to improve health of Pennsylvanians

Secretary of Health announces five health research grants to improve health of Pennsylvanians

Hepatitis C infection increases risk for developing kidney cancer

Hepatitis C infection increases risk for developing kidney cancer

Sinovac Biotech's fourth-quarter sales increase 194%

Sinovac Biotech's fourth-quarter sales increase 194%

PS-targeting antibodies can block HIV virus from entering into certain blood cells

PS-targeting antibodies can block HIV virus from entering into certain blood cells

SCYNEXIS' SCY-635 inhibitor abstracts accepted for presentation at EASL Annual Meeting

SCYNEXIS' SCY-635 inhibitor abstracts accepted for presentation at EASL Annual Meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.